Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

5. Report on workshop: Primary CNS lymphoma.

A Korfel¹, J Finke, I Schmidt-Wolf

¹Dept. of Hematology, Oncology and Transfusion Medicine, Benjamin Franklin Hospital, Free University Berlin. akorfel@hotmail.com

Annals of Hematology

|January 5, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein].

Der Urologe. Ausg. A·2018

Same author

DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.

Leukemia·2017

Same author

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.

Leukemia·2017

Same author

A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2017

Same author

Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.

Leukemia & lymphoma·2016

Same author

Detection of Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia by Analysis of Gene Rearrangements and Correlation with Early Relapses.

Leukemia & lymphoma·2016

Primary CNS lymphoma (PCNSL) management requires further research due to trial limitations. Future studies should focus on optimal chemotherapy, modern therapies like stem cell transplants, and radiotherapy impact.

Area of Science:

Neuro-oncology
Hematology
Clinical Trials

Background:

Primary CNS lymphoma (PCNSL) incidence is rising, prompting increased research interest.
Current management strategies for PCNSL face challenges due to unanswered therapeutic questions.
Existing clinical trials for PCNSL often suffer from methodological limitations, including small patient numbers and single-center designs, hindering definitive conclusions.

Framework:

Future research must address optimal chemotherapy combinations for PCNSL.
Evaluating novel therapeutic options, such as high-dose chemotherapy with autologous blood stem cell transplantation, is crucial.
Clarifying the impact of radiotherapy delays in chemotherapy responders is needed.

Implementation:

Standardized neuropsychological testing is essential for assessing treatment outcomes.

Related Experiment Videos

Quality-of-life assessments should be integrated into future PCNSL clinical trials.

Large-scale, multicenter prospective randomized trials are necessary to resolve key management questions.

Implications:

Improved understanding of PCNSL treatment efficacy and safety.
Development of evidence-based guidelines for PCNSL management.
Enhanced patient outcomes and quality of life for individuals with PCNSL.